Session 7 : India Global Collaboration in HEALTH Sector

India will be one of the largest marketplaces in the world. Foreign healthcare players need to understand how the markets work before they enter it. The Indian government is driving for Universal Health Coverage and Make in India program for affordable healthcare devices. Still private providers consume most of technologies and are the players that need to be engaged. Reverse innovation is a trend originating in India. The Indian market asks for affordable devices and provides the volumes. Cost-efficient innovative products will find markets elsewhere, too, especially in cost-strapped Western markets. The panel provides insights on market development in India, including examples of reverse innovations from India to Europe and back along with legal and IPR challenges.

Session Moderator

  • Dr. Jaanus Pikani, Chairman, ScanBalt & Tartu Biotechnology Park, Estonia

Keynote Address

  • Tanya Spisbah, Director, Australia India Institute, India


  • Dr. Jukka Holappa, Commercial Counsellor
    Country Manager India at Business Finland, India
  • Dr. Shiban Ganju, Chairman, Atrimed Pharmaceuticals, Founder, Save A Mother Foundation, USA
  • Sharda Balaji, Founder, NovoJuris Legal, India
  • Yashwant Deval, Independent consultant,  India

More panelists will be added soon…

LOCATION: Taj Vivanta, Dwarka – New Delhi
DATE: October 5, 2019
TIME: 11:00 – 12:15 hrs